(Q84834171)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21869841%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

NIH-defined graft-versus-host disease after reduced intensity or myeloablative conditioning in patients with acute myeloid leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21869841%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

main subject

acute myeloid leukemia

1 reference

T H Terwey

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21869841%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

A Vega-Ruiz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21869841%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

P G Hemmati

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21869841%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

P Martus

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21869841%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

E Dietz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21869841%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

P le Coutre

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21869841%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

G Massenkeil

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21869841%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

B Dörken

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21869841%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

R Arnold

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21869841%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

publication date

26 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21869841%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21869841%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21869841%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21869841%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

536-542

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21869841%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2011.230

11 February 2020

exact match

0 references

cites work

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.230

7 January 2021

Reduced intensity conditioning prior to allogeneic stem cell transplantation in first complete remission is effective in patients with acute myeloid leukemia and an intermediate-risk karyotype

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.230

7 January 2021

Reduced intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia: long term results of a 'donor' versus 'no donor' comparison

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.230

7 January 2021

Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.230

7 January 2021

Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective s

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.230

7 January 2021

Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.230

7 January 2021

The graft-versus-leukemia effect is mainly restricted to NIH-defined chronic graft-versus-host disease after reduced intensity conditioning before allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.230

7 January 2021

New classification of chronic GVHD: added clarity from the consensus diagnoses.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.230

7 January 2021

Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.230

7 January 2021